Cure for Ebola virus disease.

The author discusses the development of the ZMapp antiserum drug by Mapp Biopharmaceutical Inc. for the treatment of Ebola virus disease. He states that the company injected a humanised antibody into the genome of the Nicotiana, a tobacco plant, to produce an antiserum. He examines the efficacy of the ZMapp antiserum drug by looking into its possible contribution to the survival of infected American health workers Kent Brantly and Nancy Writebol.